Rattanakaemakorn, Ploysyne
Chevaisrakul, Parawee
Wongpraparut, Chanisada
Chiowchanwisawakit, Praveena
Tovanabutra, Napatra
Tantiwong, Pimchanok
Amornpinyo, Warayuwadee
Chakkavittumrong, Panlop
Hanvivadhanakul, Punchong
Chaiamnuay, Sumapa
Laodheerasiri, Supapat
Pattamadilok, Bensachee
Choonhakarn, Charoen
Mahakkanukrauh, Ajanee
Aiewruengsurat, Duangkamol
Sangmala, Siripan
Pretikul, Nisa
Sumethkul, Kittiwan
Satpanich, Panchalee
Boonsiri, Metavee
Sangob, Naruemon
Asawanonda, Pravit https://orcid.org/0000-0002-2628-0894
,
Funding for this research was provided by:
Novartis
Article History
Received: 29 August 2024
Accepted: 16 October 2024
First Online: 7 November 2024
Declarations
:
: Ploysyne Rattanakaemakorn, Parawee Chevaisrakul, Chanisada Wongpraparut, Praveena Chiowchanwisawakit, Napatra Tovanabutra, Pimchanok Tantiwong, Warayuwadee Amornpinyo, Panlop Chakkavittumrong, Punchong Hanvivadhanakul, Sumapa Chaiamnuay, Supapat Laodheerasiri, Bensachee Pattamadilok, Charoen Choonhakarn, Ajanee Mahakkanukrauh, Duangkamol Aiewruengsurat, Siripan Sangmala, Nisa Pretikul, Kittiwan Sumethkul, Panchalee Satpanich, Metavee Boonsiri, Naruemon Sangob, Pravit Asawanonda have nothing to disclose.
: This study was conducted in accordance with the principles of the Declaration of Helsinki. The Central Research Ethics Committee (COA-CREC 075/2022) and the local institutional review board (IRB) of each participating institution approved the study’s protocol. All patients were required to provide written informed consent and authorization prior to participating.